NanoEcho AB (publ) (OSTO:NANECH) Accounts Receivable : kr0.05 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is NanoEcho AB (publ) Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. NanoEcho AB (publ)'s accounts receivables for the quarter that ended in Sep. 2024 was kr0.05 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. NanoEcho AB (publ)'s Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was kr0.05.

NanoEcho AB (publ) Accounts Receivable Historical Data

The historical data trend for NanoEcho AB (publ)'s Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoEcho AB (publ) Accounts Receivable Chart

NanoEcho AB (publ) Annual Data

Trend

Dec22

Dec23

Accounts Receivable

NanoEcho AB (publ) Quarterly Data
	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24
Accounts Receivable	Get a 7-Day Free Trial			-	-	-	-	0.05

NanoEcho AB (publ) Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

NanoEcho AB (publ) Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

NanoEcho AB (publ)'s Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.045	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), NanoEcho AB (publ)'s accounts receivable are only considered to be worth 75% of book value:

NanoEcho AB (publ)'s Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(11.69	+	0.75 * 0.045	+	0.5 * 0	-	2.6
-	0	-	0)	/	173.809
=	0.05

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

NanoEcho AB (publ) Accounts Receivable Related Terms

Thank you for viewing the detailed overview of NanoEcho AB (publ)'s Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

NanoEcho AB (publ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanoEcho AB (publ) (OSTO:NANECH) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

XT4:Germany

Address

Scheelevagen 19, Lund, SWE, 223 63

Website

http://www.nanoecho.se

NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.

NanoEcho AB (publ) Headlines

No Headlines